Elie Dib is a board-certified Hematologist Oncologist practicing in the Ann Arbor metro area in Michigan. Elie has special interest in treating cancer with innovative therapies including immunotherapy and targeted therapy. His research interests are in immunogenomics.
On the national oncology level, Elie serves as a member of the Genitourinary Cancers Steering Committee (GUSC) with the NCI. He also serves as the community vice-chair for the Immuno-Oncology Committee for the Alliance for Clinical Trials in Oncology (Chicago) where he also co-chairs few national clinical trials. Elie also serves on the national TAPUR molecular tumor board with ASCO and he also enjoys working as Associate Editor for the ASCO Self Educational Program (ASCO-SEP).
In his local community, Elie serves in the role of Associate Program Director for the Hematology Oncology Fellowship training program at St Joseph Mercy Hospital in Ann Arbor as well as Deputy-Principal Investigator at the Michigan Cancer Research Consortium NCI Community Oncology Research Program (NCORP).
His educational journey in Hematology Oncology started at University of Rochester in NY and then Elie completed postgraduate education at Harvard Medical School in Cancer Biology Research with special focus on Cancer Immunotherapy and Genomics. He also holds a Master in Science in Individualized Genomics and Health from the Johns Hopkins University, Advanced Academic Programs.